Published quarterly, EPC covers the essential contract research issues between pharma companies and their CRO partners.
The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving its pharma, biotech, and CRO readership expert insight and analysis on the sponsor-service provider landscape.
EPC focusses on key trends, concerns, and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.
Prompted by the synergies between outsourcing and trial operations, EPC joined forces with its sister brand ICT in late 2015 – a move that added value to both titles. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas have unrivalled access to a wealth of shared views and analyses.
For further information please contact:
Connect with us on Twitter: follow @EPCmagazine